RejuvenRx Inc

RejuvenRx Inc is a research institute that targets diseases to the core using world-leading expertise in stem cell biology. They develop disease-modifying medicines for hematology, oncology, and aging, with a focus on myeloproliferative neoplasms and thymic rejuvenation. Their approach targets the CoREST complex, a central epigenetic regulator that controls hematopoietic stem cell self-renewal, lineage commitment, and differentiation. This complex is a key driver of stem cell aging, making it a compelling therapeutic target.